Chat with Filing

Ask questions about this document
Please log in or register to use the chat feature. Please register first.
IR - Interim Consolidated Financial Statements H1 2025 - Attachment: The Kingfish Company N.V. - Interim financial statements H1 2025.pdf

Company: The Kingfish Company Date: 2025-09-04 Language: English Register to download
Loading document preview...
Document Preview Not Available

The file type (.pdf) cannot be displayed directly here.
Open Original File
Error loading document preview. Please try the 'Open Original File' link.
You're One Click Away From The Full Filing

Instantly access this document—and 2.8M more—for free. Select your preferred method:
Continue with Google Continue with Microsoft Continue with Facebook Continue with Amazon
# Interim Condensed Consolidated Financial Statements (Unaudited)

For the 6 months ended 30 June 2025 Kats, Netherlands

# Interim Condensed Consolidated Financial Statements (Unaudited)

For the 6 months ended 30 June 2025 Kats, Netherlands

# Contents

### **[Interim management report 2](#page-3-0)**

- 2 [Company introduction](#page-3-0)
- 2 [Performance overview](#page-3-0)
- 3 [Financial instruments and](#page-4-0)  risk [management](#page-4-0)
- 3 [Employees](#page-4-0)
- 3 [Outlook](#page-4-0)

### **[Financial Performance](#page-5-0) 4**

- 4 [Interim condensed statement of](#page-5-0)  [financial](#page-5-0) position
- 5 [Interim condensed statement of profit or](#page-6-0)  [loss and other comprehensive income](#page-6-0)
- 6 [Interim condensed statement of](#page-7-0)  changes [in equity](#page-7-0)
- 7 [Interim condensed statement of](#page-8-0)  cash [flows](#page-8-0)
- 8 [Notes to the Interim Condensed](#page-9-0)  [Consolidated Financial Statements](#page-9-0)  [\(unaudited\)](#page-9-0)

![](_page_2_Picture_14.jpeg)

### <span id="page-3-0"></span>Interim management report

### Company introduction

The Kingfish Company is a pioneer and world leader in the production of sustainable yellowtail kingfish using land-based RAS. We have been producing premium yellowtail kingfish since 2017. They are also known in the marketplace as Seriola lalandi, Pacific Yellowtail, Ricciola, Greater Amberjack or Hiramasa, and often used interchangeably with Hamachi, a close cousin. Our company is on a mission to promote sustainable aquaculture, offering responsible choices to the consumer and growing awareness and care for the planet and its people.

The Kingfish Company ("the Company") is listed on Euronext Growth in Oslo (Norway), under the ticker "KING". The Kingfish Company N.V. is the parent company of the Kingfish group of companies, owning 100% of Kingfish (Netherlands) Holdings B.V., of Yellowtail Hatchery USA Inc and of Kingfish Maine Inc. Kingfish (Netherlands) Holdings B.V. owns 100% of the issued share capital of Kingfish Zeeland B.V. and Kingfish Property One B.V. The Kingfish Company owns 50% of the shares in Windfish Assets B.V. and 51% in Windfish Management B.V.

### Performance overview

In the first half of 2025, The Kingfish Company achieved a new sales record with volumes reaching 1301 tons, representing a 41% increase year-on-year, reflecting successful execution of the Company's new commercial strategy.

Revenue for the first half of the year amounted to EUR 17.0 million, a 31% increase compared to H1 2024. This growth was primarily driven by higher sales volumes. The average revenue per kilogram was temporarily lower at EUR 13.1, down from EUR 14.3 in the same period last year. This decline reflects the impact of targeted promotional pricing and a higher proportion of frozen product sales to reduce inventory levels.

Gross margin per kilogram was EUR 1.7 compared to EUR 3.6 in H1 2024. The reduction is mainly explained by the lower revenue per kilogram and temporarily elevated farming costs due to a higher FCR.

Operational EBITDA came in at EUR −2.0 per kilogram, versus EUR −1.1 per kilogram in H1 2024. This is driven by a lower gross margin partially compensated by a reduction in SG&A per kilogram as a result of higher volumes, while at the same time making significant strategic investments in commercial capabilities.

The net loss after tax for the first half of 2025 was EUR −18.5 million, compared to EUR −13.3 million in the same period of the previous year. This increase is primarily due to higher financing costs.

In light of the further increased import tariffs, an unfavorable USD exchange rate, and elevated logistics costs, Kingfish has decided to pause commercial efforts of fresh yellowtail kingfish in the United States (US), despite the strong volume growth achieved over recent quarters. While we

<sup>2</sup> The Kingfish Company N.V. Group Interim Condensed Consolidated Financial Statements (Unaudited) for the 6 months ended 30 June 2025

<span id="page-4-0"></span>continue to view the US as a strategically important and attractive market, current conditions do not support profitable operations. We will closely monitor developments and reassess our commercial strategy once the economic environment improves. Our long-term commitment to the US market remains unchanged, supported by our fully permitted Kingfish Maine project. Fresh sales in the US accounted for approximately 6% of total Fresh revenue.

In the first half of 2025, Kingfish reported an operating cash outflow of EUR 3.6 million. Furthermore, farm capex amounted to EUR 0.9 million. Financing activities contributed EUR 11.3 million, primarily driven by the successful EUR 14 million equity raise completed in January 2025. This was partially offset by EUR 1.7 million in interest payments during the second quarter. Interest on the PCP loan for the first quarter was capitalized and added to the loan balance with cash interest payments resuming in Q2.

As of 30 June, 2025, the Company maintained total liquidity of EUR 15.3 million, consisting of EUR 10.3 million in cash and cash equivalents and EUR 5.0 million in available financing facilities.

### Financial instruments and risk management

The Group's financial instruments primarily consist of cash, current receivables, payables, interest-bearing debt, and financial and operational leases. Credit risk resulting from customer non-payment is largely mitigated through an insurance contract. Similarly, all property and equipment are insured against relevant risks.

Most borrowing is at an Euribor rate plus a fixed mark up. Since May 2022, the Company had an interest rate cap in place to hedge its interest rate risks. On 30 June 2025 the interest cap came to the end of the term. The primary non-financial risk pertains to health and safety, with an ongoing emphasis on both personal and operational safety.

### Employees

As of 30 June 2025, the number of full-time equivalent (FTE) personnel remained stable at 134, unchanged from 31 December 2024. This figure includes employees of the Group's U.S. entities.

### Outlook

As The Kingfish Company continues to navigate through its sales and market development phase, we remain optimistic about the opportunities ahead. The Company is focusing on accelerating revenue growth to achieve full utilization of the production capacity, while optimizing operations and making substantial investments in sales and marketing to expand its customer base.

While the Company delivered a robust 31% increase in revenue during the first six months of 2025 compared to the same period last year, average revenue per kilogram came in below expectations. Consequently, the Company now anticipates achieving positive operational EBITDA and cash flow in 2026, representing a one- to two-quarter shift compared with its earlier expectation. The Kingfish Company continues to evaluate the timing of its expansion plans in the US and the Netherlands.

## <span id="page-5-0"></span>Interim condensed statement of financial position

as at 30 June 2025

| Figures in Euro thousand      | Notes | 30 June 2025 | 31 December 2024 |
|-------------------------------|-------|--------------|------------------|
| Assets                        |       |              |                  |
| Non-Current Assets            |       |              |                  |
| Property, plant and equipment | 3     | 115.971      | 123.098          |
| Right-of-use assets           | 4     | 2.176        | 2.364            |
| Biological assets             | 5     | 1.728        | 1.804            |
| Financial assets              | 7     | –            | 172              |
| Deferred tax                  | 8     | 17.771       | 14.422           |
|                               |       | 137.646      | 141.860          |
| Current Assets                |       |              |                  |
| Biological assets             | 5     | 9.688        | 11.223           |
| Inventories                   | 9     | 6.084        | 7.318            |
| Trade and other receivables   | 10    | 4.729        | 4.184            |
| Cash and cash equivalents     | 11    | 10.315       | 3.570            |
|                               |       | 30.816       | 26.295           |
| Total Assets                  |       | 168.462      | 168.155          |
| Equity and Liabilities        |       |              |                  |
| Equity                        |       |              |                  |
| Share capital                 | 12    | 124.672      | 111.225          |
| Reserves                      |       | 5.069        | 4.284            |
| Accumulated loss              |       | (83.422)     | (64.968)         |
|                               |       | 46.319       | 50.541           |
| Liabilities                   |       |              |                  |
| Non-Current Liabilities       |       |              |                  |
| Borrowings                    | 15    | 114.208      | 108.457          |
| Lease liabilities             | 4     | 1.217        | 1.413            |
|                               |       | 115.425      | 109.870          |
| Current Liabilities           |       |              |                  |
| Trade and other payables      | 16    | 4.622        | 5.573            |
| Borrowings                    | 15    | 1.354        | 1.391            |
| Lease liabilities             | 4     | 612          | 597              |
| Deferred income               | 17    | 85           | 97               |
| Provisions                    | 18    | 45           | 86               |
|                               |       | 6.718        | 7.744            |
| Total Liabilities             |       | 122.143      | 117.614          |
| Total Equity and Liabilities  |       | 168.462      | 168.155          |

4 The Kingfish Company N.V. Group Interim Condensed Consolidated Financial Statements (Unaudited) for the 6 months ended 30 June 2025

### <span id="page-6-0"></span>Interim condensed statement of profit or loss and other comprehensive income

| Figures in Euro thousand                                                         | Notes  | 6 months ended<br>30 June 2025 | 6 months ended<br>30 June 2024 |
|----------------------------------------------------------------------------------|--------|--------------------------------|--------------------------------|
| Continuing operations                                                            |        |                                |                                |
| Revenue                                                                          | 19     | 17.046                         | 13.049                         |
| Other operating income                                                           | 20     | 44                             | 84                             |
| Other operating gains (losses)                                                   | 21     | (360)                          | 36                             |
| Stock movements and transport and logistics cost                                 | 22     | (4.023)                        | 2.271                          |
| Raw materials                                                                    | 22     | (8.466)                        | (8.410)                        |
| Employee costs                                                                   | 23     | (5.876)                        | (5.379)                        |
| Lease expenses                                                                   | 23     | (142)                          | (233)                          |
| Depreciation, amortization and impairment expenses                               | 23     | (7.150)                        | (7.159)                        |
| Other operating expenses                                                         |        | (3.791)                        | (3.526)                        |
| Operating loss                                                                   | 23     | (12.718)                       | (9.267)                        |
| Finance costs                                                                    | 24     | (8.680)                        | (5.928)                        |
| Loss before taxation                                                             |        | (21.398)                       | (15.195)                       |
| Taxation                                                                         | 25     | 3.350                          | 2.087                          |
| Loss for the period from continuing operations                                   |        | (18.048)                       | (13.108)                       |
| Discontinued operations                                                          |        |                                |                                |
| Loss for the period from discontinued operations                                 | 26     | (406)                          | (204)                          |
| Loss for the 6 months                                                            |        | (18.454)                       | (13.312)                       |
| Other comprehensive income:                                                      |        |                                |                                |
| Items that may be reclassified to profit or loss:                                |        |                                |                                |
| Exchange differences on translating foreign operations                           | 762    | (63)                           |                                |
| Deferred cost of hedging on cash flow hedges not subject to basis<br>adjustments | (56)   | (11)                           |                                |
| Total items that may be reclassified to profit or loss                           |        | 706                            | (74)                           |
| Other comprehensive income for the 6 months net of taxation                      | 28     | 706                            | (74)                           |
| Total comprehensive loss for the 6 months                                        |        | (17.748)                       | (13.386)                       |
| Earnings per share                                                               |        |                                |                                |
| From continuing operations                                                       |        |                                |                                |
| Basic loss per share (c)                                                         | 30     | (0,12)                         | (0,11)                         |
| Diluted loss per share (c)                                                       | (0,12) | (0,11)                         |                                |
| From discontinuing operations                                                    |        |                                |                                |
| Basic loss per share (c)                                                         | (0,01) | (0,01)                         |                                |
| Diluted loss per share (c)                                                       | (0,01) | (0,01)                         |                                |

## <span id="page-7-0"></span>Interim condensed statement of changes in equity

| Figures in Euro thousand                                                                        | Share capital | premium<br>Share | Total share<br>capital | translation<br>currency<br>Foreign<br>reserve | Cash flow<br>hedging<br>reserve | Share option<br>reserve | instruments<br>Convertible<br>reserve | Total reserves | Accumulated<br>loss | Total equity |
|-------------------------------------------------------------------------------------------------|---------------|------------------|------------------------|-----------------------------------------------|---------------------------------|-------------------------|---------------------------------------|----------------|---------------------|--------------|
| Balance at 1 January 2024                                                                       | 1.108         | 110.117          | 111.225                | (1)                                           | 798                             | 1.284                   | 2.981                                 | 5.062          | (34.185)            | 82.102       |
| Loss for the 6 months                                                                           | –             | –                | –                      | –                                             | –                               | –                       | –                                     | –              | (13.312)            | (13.312)     |
| Other comprehensive income                                                                      | –             | –                | –                      | (63)                                          | (11)                            | –                       | –                                     | (74)           | –                   | (74)         |
| Total comprehensive Loss<br>for the 6 months ending<br>30 June 2024                             | –             | –                | –                      | (63)                                          | (11)                            | –                       | –                                     | (74)           | –                   | (74)         |
| Employees share option expense<br>until 30 June 2024                                            | –             | –                | –                      | –                                             | –                               | 58                      | –                                     | 58             | –                   | 58           |
| Employees share option expense<br>until 31 December 2024                                        | –             | –                | –                      | –                                             | –                               | 155                     | –                                     | 155            | –                   | 155          |
| Loss for the 6 months ending<br>31 December 2024                                                | –             | –                | –                      | –                                             | –                               | –                       | –                                     | –              | (17.417)            | (17.471)     |
| Other comprehensive income<br>for the 6 months ending<br>31 December 2024                       | –             | –                | –                      | (186)                                         | (731)                           | –                       | –                                     | (917)          | –                   | (917)        |
| Total contributions by and<br>distributions to owners of group<br>recognized directly in equity | –             | –                | –                      | (186)                                         | (731)                           | 213                     | –                                     | (704)          | (17.471)            | (18.175)     |
| Balance at 1 January 2025                                                                       | 1.108         | 110.117          | 111.225                | (250)                                         | 56                              | 1.497                   | 2.981                                 | 4.284          | (64.968)            | 50.541       |
| Loss for the 6 months                                                                           | –             | –                | –                      | –                                             | –                               | –                       | –                                     | –              | (18.454)            | (18.454)     |
| Other comprehensive income                                                                      | –             | –                | –                      | 762                                           | (56)                            | –                       | –                                     | 706            | –                   | 706          |
| Total comprehensive Loss<br>for the 6 months ending<br>30 June 2025                             | –             | –                | –                      | 762                                           | (56)                            | –                       | –                                     | 706            | (18.454)            | (17.748)     |
| Issue of shares                                                                                 | 319           | 14.011           | 14.330                 |                                               |                                 |                         |                                       |                |                     | 14.330       |
| Employees share option expense                                                                  | –             | –                | –                      | –                                             | –                               | 79                      | –                                     | 79             | –                   | 79           |
| Funding Fee                                                                                     | –             | (883)            | (883)                  | –                                             | –                               | –                       | –                                     | –              | –                   | (883)        |
| Total contributions by and<br>distributions to owners of group<br>recognized directly in equity | 319           | 13.128           | 13.447                 | –                                             | –                               | 79                      | –                                     | 79             | –                   | 13.526       |
| Balance at 30 June 2025                                                                         | 1.427         | 123.245          | 124.672                | 512                                           | –                               | 1.576                   | 2.981                                 | 5.069          | (83.422)            | 46.319       |
| Notes                                                                                           | 12            | 12               | 12                     | 14&28                                         | 28                              | 13                      |                                       |                |                     |              |

6 The Kingfish Company N.V. Group Interim Condensed Consolidated Financial Statements (Unaudited) for the 6 months ended 30 June 2025

## <span id="page-8-0"></span>Interim condensed statement of cash flows

| Figures in Euro thousand                    | Notes | 6 months ended<br>30 June 2025 | 6 months ended<br>30 June 2024 |
|---------------------------------------------|-------|--------------------------------|--------------------------------|
| Cash flows from operating activities        |       |                                |                                |
| Cash receipts from customers                |       | 16.283                         | 12.855                         |
| Cash paid to suppliers and employees        |       | (19.904)                       | (18.378)                       |
| Cash utilized in operations                 | 29    | (3.621)                        | (5.523)                        |
| Net cash from operating activities          |       | (3.621)                        | (5.523)                        |
| Cash flows from investing activities        |       |                                |                                |
| Investment in property, plant and equipment | 3     | (951)                          | (3.343)                        |
| Net cash from investing activities          |       | (951)                          | (3.343)                        |
| Cash flows from financing activities        |       |                                |                                |
| Net proceeds on share issue                 | 12    | 13.447                         | –                              |
| Proceeds/(Repayment) of borrowings          |       | (1.921)                        | 1.792                          |
| Net movement of lease liabilities           |       | (181)                          | 229                            |
| Finance costs on leases                     |       | (28)                           | (31)                           |
| Net cash from financing activities          |       | 11.317                         | 1.990                          |
| Total cash movement for the 6 months        |       | 6.745                          | (6.876)                        |
| Cash at the beginning of the 6 months       |       | 3.570                          | 19.533                         |
| Total cash at end of the 6 months           | 11    | 10.315                         | 12.657                         |

### <span id="page-9-0"></span>1. Group information

The Kingfish Company N.V. group engages in the production and supply of sustainable, safe and high quality seafood in its target markets.

Fingerlings are produced all year around and are not exposed to seasonality. Growth performance varies per batch grown on the farm.

The interim condensed consolidated financial statements of The Kingfish Company N.V. group for the 6 months ended 30 June 2025 were authorized for issue by the Executive Board on 3 September 2025.

### 1.1 Basis of preparation

The unaudited interim condensed consolidated financial statements have been prepared in accordance with the accounting principles IAS 34 Interim Financial Reporting. The accompanying interim condensed consolidated financial statements are unaudited and reflect all material adjustments necessary for a fair statement of the financial position, results of operations and cash flows for the interim period presented in conformity with IAS 34.

The 31 December 2024 condensed consolidated balance sheet data was derived from audited consolidated financial statements for the year ended 31 December 2024, which include all disclosures required by IFRS. Therefore, these interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements of the Company. The results of operations for the six months ended 30 June 2025 are not necessarily indicative of the results for any subsequent periods or the entire fiscal year ending 31 December 2025.

The preparation of financial statements in conformity with IFRS requires the Company to make estimates and assumptions that affect the amounts reported in the interim condensed consolidated financial statements and accompanying notes. Amounts based on such estimates involve numerous assumptions subject to varying and potentially significant degrees of judgement and uncertainty, particularly related to the future performance of the underlying business. Actual experience could materially differ from these estimates and assumptions. The most significant estimates are those used in calculating the fair market value of the biological assets.

The unaudited interim condensed consolidated financial statements have been prepared on the basis that the Company will continue to operate as a going concern. Refer to Note 31 for additional details regarding the going concern assumption.

8 The Kingfish Company N.V. Group Interim Condensed Consolidated Financial Statements (Unaudited) for the 6 months ended 30 June 2025

### 2. New Standards and Interpretations

### 2.1 Standards and interpretations effective and adopted in the current 6 months

The accounting policies adopted in the preparation of the group's annual consolidated financial statements are consistent with those followed in the preparation of the group's annual consolidated financial statements for the year ended 31 December 2024, except for the adoption of new standards effective as of 1 January 2025.

The below newly effective IFRS Accounting Standards have been evaluated by the group to determine whether and if, to what extend the expected impact will be on the group. The group has not adopted any standard, interpretation or amendment that has been issued but is not yet effective.

| Standard/Interpretation:                          | Effective date:<br>Years beginning on or after | Expected impact:                                                                                                                                                                                                               |
|---------------------------------------------------|------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Lack of Exchangeability –<br>Amendments to IAS 21 | 1 January 2025                                 | The amendments to IAS 21 regarding the lack of<br>exchangeability are unlikely to have a material impact, as<br>the group primarily operate in Europe and the US,<br>transacting in stable and freely exchangeable currencies. |

### 2.2 Standards and interpretations not yet effective

The group has chosen not to early adopt the following standards and interpretations, which have been published and are mandatory for the group's accounting periods beginning on or after 1 January 2026 or later periods:

| Standard/Interpretation:                                                                           | Effective date:<br>Years beginning on or after | Expected impact:                                                                                                                                                                                                                                                                                                                                                                          |
|----------------------------------------------------------------------------------------------------|------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Classification and Measurement<br>of Financial Instruments –<br>Amendments to IFRS 9 and<br>IFRS 7 | 1 January 2026                                 | These amendments clarify derecognition timing for<br>financial assets and liabilities and introduce guidance for<br>evaluating contractual cash flow characteristics,<br>including ESG-linked features. New disclosure<br>requirements are also introduced. The group does not<br>expect a material impact as its financial instruments are<br>not significantly affected by the changes. |
| Nature-dependent Electricity<br>Contracts – Amendments to IFRS<br>9 and IFRS 7                     | 1 January 2026                                 | These amendments address the treatment of "own use"<br>electricity contracts and related hedge accounting under<br>IFRS 9. The group does not expect the<br>impact to be material.                                                                                                                                                                                                        |

### 3. Property, plant and equipment

|                              | 2025                   |                             |                   | 2024                   |                             |                   |
|------------------------------|------------------------|-----------------------------|-------------------|------------------------|-----------------------------|-------------------|
|                              | Cost or<br>revaluation | Accumulated<br>depreciation | Carrying<br>value | Cost or<br>revaluation | Accumulated<br>depreciation | Carrying<br>value |
| Land and buildings           | 63.327                 | (9.253)                     | 54.074            | 60.089                 | (7.723)                     | 52.366            |
| Equipment                    | 75.903                 | (23.705)                    | 52.198            | 77.937                 | (18.558)                    | 59.379            |
| Motor vehicles               | 53                     | (45)                        | 8                 | 53                     | (42)                        | 11                |
| Office equipment             | 1.208                  | (749)                       | 459               | 1.187                  | (649)                       | 538               |
| Assets under<br>construction | 9.232                  | –                           | 9.232             | 10.804                 | –                           | 10.804            |
| Total                        | 149.723                | (33.752)                    | 115.971           | 150.070                | (26.972)                    | 123.098           |

### Reconciliation of property, plant and equipment – 2025

|                              | Opening balance | Additions | Reclassification | Forex adjustment | Depreciation | Total   |
|------------------------------|-----------------|-----------|------------------|------------------|--------------|---------|
| Land and buildings           | 52.366          | 724       | 2.514            | –                | (1.530)      | 54.074  |
| Equipment                    | 59.379          | 159       | (2.158)          | –                | (5.182)      | 52.198  |
| Motor vehicles               | 11              | –         | –                | –                | (3)          | 8       |
| Office equipment             | 538             | 9         | 12               | –                | (100)        | 459     |
| Assets under<br>construction | 10.804          | 59        | (368)            | (1.263)          | –            | 9.232   |
|                              | 123.098         | 951       | –                | (1.263)          | (6.815)      | 115.971 |

#### Reconciliation of property, plant and equipment – 2024

|                              | Opening balance | Additions | Disposals | Forex adjustment | Depreciation | Total   |
|------------------------------|-----------------|-----------|-----------|------------------|--------------|---------|
| Land and buildings           | 54.961          | 415       | –         | –                | (3.010)      | 52.366  |
| Equipment                    | 67.601          | 2.622     | (560)     | 138              | (10.422)     | 59.379  |
| Motor vehicles               | 17              | –         | –         | –                | (6)          | 11      |
| Office equipment             | 732             | 4         | –         | –                | (198)        | 538     |
| Assets under<br>construction | 8.055           | 2.112     | –         | 637              | –            | 10.804  |
|                              | 131.366         | 5.153     | (560)     | 775              | (13.636)     | 123.098 |

#### Property, plant and equipment encumbered as security

Assets have been pledged as security for the secured long-term borrowings. Refer to note 15.

#### Assets under construction

Assets under construction as of 30 June 2025 mainly relates to the initial investments for a farm in the USA (9.205k EUR) and the remainder relates to our operations in Netherlands.

|                          | 6 months ended | 12 months ended  |
|--------------------------|----------------|------------------|
| Figures in Euro thousand | 30 June 2025   | 31 December 2024 |

### 4. Leases (group as lessee)

The group has lease contracts for various motor vehicles, production equipment and buildings in its operations. Leases of motor vehicles and production equipment generally have lease terms of between 5 and 7 years and buildings between 3 and 20 years. The group's obligations under its leases are secured by the lessor's title to the leased assets. Generally, the group is restricted from assigning and subleasing the leased assets.

Details pertaining to leasing arrangements, where the group is lessee are presented below:

| Net carrying amounts of right-of-use assets                 |       |       |
|-------------------------------------------------------------|-------|-------|
| The carrying amounts of right-of-use assets are as follows: |       |       |
| Buildings                                                   | 57    | 64    |
| Equipment                                                   | 1.684 | 1.916 |
| Motor vehicles                                              | 435   | 384   |
|                                                             | 2.176 | 2.364 |
| Lease liabilities                                           |       |       |
| The maturity analysis of lease liabilities are as follows:  |       |       |
| Within one year                                             | 657   | 646   |
| Two to five years                                           | 1.142 | 1.342 |
| More than five years                                        | 169   | 180   |
|                                                             | 1.968 | 2.168 |
| Less finance charges component                              | (139) | (158) |
|                                                             | 1.829 | 2.010 |
|                                                             |       |       |
| Non-current liabilities                                     | 1.217 | 1.413 |
| Current liabilities                                         | 612   | 597   |
|                                                             | 1.829 | 2.010 |
|                                                             | 2025  | 2024  |
| As at 1 January                                             | 2.010 | 1.920 |
| Additions                                                   | 127   | 802   |
| Interest                                                    | 28    | 62    |
| Payments                                                    | (336) | (774) |
| As at 30 June/31 December                                   | 1.829 | 2.010 |

### 5. Biological assets

|                 | 2025                 |                             |                | 2024                 |                             |                |
|-----------------|----------------------|-----------------------------|----------------|----------------------|-----------------------------|----------------|
|                 | Cost or<br>Valuation | Accumulated<br>depreciation | Carrying value | Cost or<br>Valuation | Accumulated<br>depreciation | Carrying value |
| Live stock fish | 9.688                | –                           | 9.688          | 11.223               | –                           | 11.223         |
| Broodstock      | 1.728                | –                           | 1.728          | 1.804                | –                           | 1.804          |
| Total           | 11.416               | –                           | 11.416         | 13.027               | –                           | 13.027         |

#### Reconciliation of biological assets – 2025

|                 | Opening<br>balance | Increase due<br>to production | Decreases<br>due to<br>harvest/sales | Decreases due<br>to mortality<br>and selection | Gains (losses)<br>arising from<br>changes in fair value | Total  |
|-----------------|--------------------|-------------------------------|--------------------------------------|------------------------------------------------|---------------------------------------------------------|--------|
| Live fish stock | 11.223             | 16.969                        | (17.354)                             | (438)                                          | (712)                                                   | 9.688  |
| Broodstock      | 1.804              | –                             | –                                    | –                                              | (76)                                                    | 1.728  |
|                 | 13.027             | 16.969                        | (17.354)                             | (438)                                          | (788)                                                   | 11.416 |

#### Reconciliation of biological assets – 2024

|                 | Opening<br>balance | Increase due<br>to production | Decreases<br>due to<br>harvest/sales | Decreases due<br>to mortality<br>and selection | Gains (losses)<br>arising from<br>changes in fair value | Total  |
|-----------------|--------------------|-------------------------------|--------------------------------------|------------------------------------------------|---------------------------------------------------------|--------|
| Live fish stock | 13.402             | 33.611                        | (32.252)                             | (1.974)                                        | (1.564)                                                 | 11.223 |
| Broodstock      | 1.382              | 196                           | –                                    | –                                              | 226                                                     | 1.804  |
|                 | 14.784             | 33.807                        | (32.252)                             | (1.974)                                        | (1.338)                                                 | 13.027 |

#### As of 30 June 2025 and 31 December 2024, the group's physical volumes of biological assets consisted of the following:

|                                                                             | 2025   | 2024   |
|-----------------------------------------------------------------------------|--------|--------|
| Live fish weight (in tons)                                                  | 972    | 1 118  |
| Number of fish (in thousands)                                               | 1 238  | 1 430  |
| Volume of fish harvested during the 6 months/year (tons whole round weight) | 1 362  | 2 323  |
| Net biological assets                                                       |        |        |
| Non-current assets                                                          | 1.728  | 1.804  |
| Current assets                                                              | 9.688  | 11.223 |
|                                                                             | 11.416 | 13.027 |

| Figures in Euro thousand | 6 months ended<br>30 June 2025 | 12 months ended<br>31 December 2024 |
|--------------------------|--------------------------------|-------------------------------------|
|--------------------------|--------------------------------|-------------------------------------|

### 6. Fair value information

### Fair value hierarchy

The table below analyses assets carried at fair value. The different levels are defined as follows:

Level 1: Quoted unadjusted prices in active markets for identical assets or liabilities that the group can access at measurement date.

Level 2: Inputs other than quoted prices included in level 1 that are observable for the asset or liability either directly or indirectly.

Level 3: Unobservable inputs for the asset or liability.

#### Levels of fair value measurements

#### Level 3

#### Recurring fair value measurements

| Assets                  | Note |        |        |
|-------------------------|------|--------|--------|
| Biological assets       | 5    |        |        |
| Live fish stock         |      | 9.688  | 11.223 |
| Broodstock              |      | 1.728  | 1.804  |
| Total biological assets |      | 11.416 | 13.027 |
| Total                   |      | 11.416 | 13.027 |

#### Reconciliation of assets and liabilities measured at level 3

#### 30 June 2025/31 December 2024

Refer to note 5 for the movement in fair value.

Movements within the fair value of live fish stock is recognized within cost of sale and movements within broodstock is recognized in fair value adjustments.

#### Information about valuation techniques and inputs used to derive level 3 fair values

#### Biological assets – live fish stock

The key unobservable inputs, together with the weighted average range of probabilities, are as follows:

Biomass quantity is recorded upon grading of fish at younger ages into individual tanks and adjusted for actual mortalities recorded per tank. Total weight is calculated upon grading of fish and continually adjusted based on a feed intake based model. The average weight of fish per tank is regularly controlled by way of sampling of fish from each tank, where after adjustments are made to reflect the sample results. Although some degree of variation is expected, actual fish size is not expected to deviate substantially from the average sampling size.

| Figures in Euro thousand | 6 months ended<br>30 June 2025 | 12 months ended<br>31 December 2024 |
|--------------------------|--------------------------------|-------------------------------------|
|--------------------------|--------------------------------|-------------------------------------|

### 6. Fair value information *(continued)*

The fair value of the group's biological assets was calculated based on different parameters. The key element in the fair value model of biological assets is the price that is expected to be received in the future when the fish is harvested. This fair value calculation is based on realized sales and cost to sell per size-category around balance sheet date. The average fair value per kilogram as of 30 June 2025 and 31 December 2024 was as follows:

|                                              | Price range in €/kg |       | Counts(thousand units) |       |
|----------------------------------------------|---------------------|-------|------------------------|-------|
|                                              | 2025                | 2024  | 2025                   | 2024  |
| Average fair value of live stock fish per kg | 9,97                | 10,04 | 1,238                  | 1,430 |

Fish under 700 grams are valued between EUR 3 and EUR 5.60 each.

Incident based Mortality

No significant mortality incidents were noted for the period ended 30 June 2025 and 31 December 2024.

### 7. Financial assets

| Hedging derivatives                            |   |     |
|------------------------------------------------|---|-----|
| Rabobank interest cap                          | – | 172 |
| Split between non-current and current portions |   |     |
| Non-current assets                             | – | 172 |

#### Rabobank interest cap

The Kingfish Company N.V group entered into an interest cap transaction with Rabobank on 27 May 2022 and paid a fixed premium of EUR 841.000. The notional amount is EUR 75.000.000 and the transaction is for a period of 3 years.

The transaction caps EURIBOR at 2% on the loan with P Capital Partner AB and the floating amount payment dates commence on 30 September 2022 and then every 3 months thereafter on the last day of the month up to and including the termination date.

On 30 June 2025 the interest cap with Rabobank came to the end of the term.

| Figures in Euro thousand | 6 months ended<br>30 June 2025 | 12 months ended<br>31 December 2024 |
|--------------------------|--------------------------------|-------------------------------------|
|                          |                                |                                     |

### 8. Deferred tax

| Deferred tax asset                                                                                                                                                                                                                 |        |        |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|--------|
| Deferred tax losses available for offsetting against future taxable income                                                                                                                                                         | 17.771 | 14.422 |
| The deferred tax assets and the deferred tax liability relate to income tax in<br>the same jurisdiction, and the law allows net settlement. Therefore, they have<br>been offset in the statement of financial position as follows: |        |        |
| Deferred tax asset                                                                                                                                                                                                                 | 17.771 | 14.422 |
| Reconciliation of deferred tax asset/(liability)                                                                                                                                                                                   |        |        |
| At beginning of year                                                                                                                                                                                                               | 14.422 | 9.234  |
| Increases (decrease) in tax loss available for set off against future taxable<br>income – gross of valuation allowance (US and NL)                                                                                                 | 3.349  | 5.188  |
|                                                                                                                                                                                                                                    | 17.771 | 14.422 |

### Recognition of deferred tax asset

Deferred income tax assets relate to unutilized tax losses. These losses are expected to be offset with future profits.

### 9. Inventories

|                               | 6.084 | 7.318 |
|-------------------------------|-------|-------|
| Finished goods – frozen fish  | 3.486 | 4.880 |
| Raw materials and consumables | 2.598 | 2.438 |

Write-downs of inventories were minimal. The write-downs were recognized as an expense during the period ended 30 June 2025 and 31 December 2024 and included in cost of sales in the statement of profit or loss. All inventories are reviewed regularly to ensure that it is measured at the lower of cost or net realizable value.

| Figures in Euro thousand            | 6 months ended<br>30 June 2025 | 12 months ended<br>31 December 2024 |
|-------------------------------------|--------------------------------|-------------------------------------|
|                                     |                                |                                     |
| 10.<br>Trade and other receivables  |                                |                                     |
| Financial instruments:              |                                |                                     |
| Trade receivables                   | 4.218                          | 3.311                               |
| Accrued income                      | –                              | 6                                   |
| Loss allowance                      | (106)                          | (113)                               |
| Trade receivables at amortized cost | 4.112                          | 3.204                               |
| Deposits                            | 43                             | 62                                  |
| Non-financial instruments:          |                                |                                     |
| VAT                                 | 204                            | 204                                 |
| Prepayments                         | 370                            | 714                                 |
| Total trade and other receivables   | 4.729                          | 4.184                               |

#### Exposure to credit risk

Trade receivables inherently expose the company to credit risk, being the risk that the company will incur financial loss if customers fail to make payments as they fall due.

|                                        | 2025                                                | 2025                                                    | 2024                                                | 2024                                                    |
|----------------------------------------|-----------------------------------------------------|---------------------------------------------------------|-----------------------------------------------------|---------------------------------------------------------|
| Credit risk exposure by aging category | Estimated<br>gross carrying<br>amount at<br>default | Loss allowance<br>(Lifetime<br>expected credit<br>loss) | Estimated<br>gross carrying<br>amount at<br>default | Loss allowance<br>(Lifetime<br>expected credit<br>loss) |
| Not past due:                          | 3.343                                               | 42                                                      | 2.661                                               | 40                                                      |
| Less than 30 days past due:            | 879                                                 | 38                                                      | 601                                                 | 10                                                      |
| 31–60 days past due:                   | 137                                                 | 12                                                      | 57                                                  | 1                                                       |
| 61–90 days past due:                   | 12                                                  | 2                                                       | 37                                                  | 1                                                       |
| 91–120 days past due:                  | 12                                                  | 12                                                      | 61                                                  | 61                                                      |
| Total                                  | 4.383                                               | 106                                                     | 3.417                                               | 113                                                     |

#### Reconciliation of loss allowances

The following table shows the movement in the loss allowance (lifetime expected credit losses) for lease receivables:

| Opening balance                               | (113) | (82)  |
|-----------------------------------------------|-------|-------|
| Remeasurement of loss allowance – comparative | 7     | (31)  |
| Closing balance                               | (106) | (113) |

| Figures in Euro thousand                             | 6 months ended<br>30 June 2025 | 12 months ended<br>31 December 2024 |  |
|------------------------------------------------------|--------------------------------|-------------------------------------|--|
| 11.<br>Cash and cash equivalents                     |                                |                                     |  |
| Cash and cash equivalents consist of:                |                                |                                     |  |
| Bank balances                                        | 10.315                         | 3.570                               |  |
| 12.<br>Share capital<br>Authorized                   |                                |                                     |  |
| 550.000.000 Ordinary shares of par value of EUR 0,01 | 5.500                          | 5.500                               |  |
| Reconciliation of number of shares issued:           |                                |                                     |  |
| Reported as at 1 January 2025/2024                   | 110.850                        | 110.850                             |  |
| Issue of shares – ordinary shares                    | 31.844                         | –                                   |  |
|                                                      | 142.694                        | 110.850                             |  |
| Issued                                               |                                |                                     |  |
| Ordinary                                             | 1.427                          | 1.108                               |  |
| Share premium                                        | 128.305                        | 114.294                             |  |
| Share issue costs written off against share premium  | (5.060)                        | (4.177)                             |  |
|                                                      | 124.672                        | 111.225                             |  |

During 2025 31.111.112 common shares with a nominal value of EUR 0,01 were issued for EUR 14 million. Costs of EUR 883k were offset against this equity raise. There was also an underwriting commitment fee resulting in the issuance of a further 733.333 common shares.

All issued shares are fully paid.

The shareholders shall have the right to vote in respect of the Shares in which an usufruct has been created. However, the beneficiary of an usufruct shall be entitled to vote, if this was so provided for at the creation of the usufruct. Shares may be pledged as security. The Shareholder shall have the right to vote in respect of the Shares which have been pledged. However, the voting rights shall accrue to the pledgee, if this was provided for at the creation of the pledge. The Receipt Holder's Right shall vest in a Shareholder who in consequence of usufruct or a pledge created on his Shares is not entitled to vote, and in usufructuaries and pledges who are entitled to vote. The Receipt Holder's Rights shall not vest in usufructuaries and pledgees who are not entitled to vote.

**Figures in Euro thousand**

**6 months ended 30 June 2025 12 months ended 31 December 2024**

### 13. Share based payments

| Details                                | Total<br>Options @<br>Eur 1,2788 | Vested    | Total<br>Options @<br>Eur 2,53 | Vested  | Total<br>Options @<br>Eur 1,90 | Vested  | Total<br>Options @<br>Eur 1,00 | Vested  |
|----------------------------------------|----------------------------------|-----------|--------------------------------|---------|--------------------------------|---------|--------------------------------|---------|
| O. Maiman                              | 591.908                          | 591.908   | –                              | –       | –                              | –       | –                              | –       |
| C.J. Kloet                             | 607.717                          | 607.717   | –                              | –       | –                              | –       | –                              | –       |
| Senior management                      | 300.508                          | 300.508   | –                              | –       | –                              | –       | 120.000                        | 60.000  |
| J.C. Valette                           | –                                | –         | –                              | –       | 180.000                        | 110.000 | –                              | –       |
| Direct reports to<br>senior management | –                                | –         | 170.000                        | 170.000 | –                              | –       | 225.000                        | 112.500 |
| Other eligible<br>employees            | –                                | –         | 20.000                         | 20.000  | –                              | –       | –                              | –       |
|                                        | 1.500.133                        | 1.500.133 | 190.000                        | 190.000 | 180.000                        | 110.000 | 345.000                        | 172.500 |

| Details                                | Total<br>Options @<br>Eur 0,93 | Vested | Total<br>Options @<br>Eur 0,77 | Vested  | Total<br>Options @<br>Eur 0,85 | Vested | Total<br>Options @<br>Eur 0,60 | Vested |
|----------------------------------------|--------------------------------|--------|--------------------------------|---------|--------------------------------|--------|--------------------------------|--------|
| V. Erenst                              | 200.000                        | 94.444 | –                              | –       | –                              | –      | 100.000                        | –      |
| J.C. Valette                           | –                              | –      | 90.000                         | 40.000  | –                              | –      | 100.000                        | –      |
| Senior management                      | –                              | –      | 150.254                        | 66.780  | –                              | –      | 270.000                        | –      |
| Direct reports to<br>senior management | –                              | –      | 60.000                         | 26.667  | 50.000                         | 19.444 | 650.000                        | –      |
| Other eligible<br>employees            | –                              | –      | –                              | –       | –                              | –      | 85.000                         | –      |
|                                        | 200.000                        | 94.444 | 300.254                        | 133.447 | 50.000                         | 19.444 | 1.205.000                      | –      |

On 30 October 2020, at an extraordinary general meeting an employee stock option plan (ESOP) was approved, pursuant to which options for a total of 4.006.762 common shares may be awarded to members of the mid- and senior management and key employees, equivalent to approximately 8,8% of the then issued share capital on a fully diluted basis. On 19 June 2024, at an annual general meeting there was an increase in the common shares, which may be awarded to members of the mid- and senior management and key employees, to 6.000.000 common shares. This decision led to an equivalent to approximately 5,5% of the issued share capital on a fully diluted basis. Options are granted to key employees based on their role, seniority, and specific expertise considered critical to the Group, particularly in aquaculture and business development, with the primary objective of retaining essential talent. A four year vesting schedule applies to each grant under the ESOP including an one-year cliff during which no options vest. After the one-year cliff awarded options vest in 36 equal monthly numbers. Vesting is based on the recipient remaining in service and contains bad leaver provisions. The clawback provision in the ESOP allows the company to reclaim or cancel share options under specific circumstances. If an employee leaves the company under certain conditions (such as resignation or dismissal for cause), their vested options may be forfeited, and in some cases, exercised options may also be subject to reimbursement by the employee. As at the reporting date 3.970.387 options were issued with 2.219.968 already being vested.

18 The Kingfish Company N.V. Group Interim Condensed Consolidated Financial Statements (Unaudited) for the 6 months ended 30 June 2025

| Figures in Euro thousand | 6 months ended<br>30 June 2025 | 12 months ended<br>31 December 2024 |
|--------------------------|--------------------------------|-------------------------------------|
|--------------------------|--------------------------------|-------------------------------------|

### 13. Share based payments *(continued)*

The exercise price is based on the value of the shares when capital was raised or latest average price on the exchange. The expected volatility is 40% based on similar companies listed for a couple of years. The model is based on a 10 year expiration date with no expected dividends, the risk-free interest rate is assumed at 1,55%, the average fair value is EUR 0,46 at the end of June 2025 and the last options vesting 30 June 2028.

Based on the Binomial compensation model, an amount of EUR 78.714 (2024: 58.028) was recognized in the P&L versus equity under Share options reserve. This amount represents the potential cost of the ESOP and has not been paid.

### 14. Foreign currency translation reserve

| Translation reserve comprises exchange differences on consolidation of<br>foreign subsidiaries. |     |       |
|-------------------------------------------------------------------------------------------------|-----|-------|
| Kingfish Maine Inc.                                                                             | 212 | (54)  |
| Kingfish Yellowtail USA Inc.                                                                    | 300 | (196) |
|                                                                                                 | 512 | (250) |

### 15. Borrowings

| Held at amortized cost                         |         |         |
|------------------------------------------------|---------|---------|
| P Capital Partner AB                           | 75.357  | 73.063  |
| Convertible loan                               | 38.851  | 35.394  |
| Machias loan                                   | 1.354   | 1.391   |
|                                                | 115.562 | 109.848 |
| Split between non-current and current portions |         |         |
| Non-current liabilities                        | 114.208 | 108.457 |
| Current liabilities                            | 1.354   | 1.391   |
|                                                | 115.562 | 109.848 |
|                                                |         |         |

### P Capital Partners AB

The loan with P Capital Partners AB consists of facility A, B and C. Facility A is EUR 19.000.000 and this facility was used to repay the loans and leases with Rabobank. Facility B is for an amount of EUR 45.000.000 and is used to cover capex of phase 2 and working capital and facility C is EUR 11.000.000 and this is used to cover the interest and commitment fees payable on both facility A and B.

Interest is the aggregate of 8%, minus a maximum of 1.5% for meeting the sustainability targets, and EURIBOR 3 months (with a minimum of 0%) and is payable on a quarterly basis. A commitment fee of 2% is payable on the part of the loan that is not utilized and are payable on the last day of each successive period of three months. An arrangement fee of 1% is payable on every amount requested.

Property, plant and equipment, biological assets, inventory, trade and other receivables, cash and cash equivalents and share capital have been pledged as security.

**Figures in Euro thousand**

**6 months ended 30 June 2025**

**12 months ended 31 December 2024**

### 15. Borrowings *(continued)*

Convertible loan

The Kingfish Company N.V. successfully raised EUR 32 million in an unsecured convertible loan in 2023. The majority of the convertible loan was allocated to existing key shareholders, while EUR 11 million was allocated to a new investor. The duration of the convertible loan is 4 years.

The Convertible Loan is split into two tranches:

- Tranche 1 consists of EUR 10 million, based on the authorization granted by the company's annual general meeting held on June 20, 2023. The supervisory board has resolved to grant 10,763,182 rights to subscribe for shares (of which each right gives a right to subscribe for one new share) to the lenders (excluding Ocean 14); and
- Tranche 2 consists of EUR 22 million. At the EGM held on July 24, 2023, the supervisory board was granted the right to issue and/or grant rights to subscribe for up to a maximum of 70 million shares.

On June 29, 2023, The Kingfish Company entered into a EUR 5 million loan agreement. On July 5, 2023, this loan amount was settled with the issuance of Tranche 1 of the convertible loan agreement of EUR 32 million. The convertible loan carries a fixed interest rate of 15% per annum.

The drawdown date for Tranche 1 was July 5, 2023, for Tranche 2 the drawdown date was August 17, 2023.

At any time following the relevant drawdown date, each lender may convert its part of the convertible loan, including any accrued and unpaid interest and any underwriting commission, into shares, each with a nominal value of EUR 0.01, at a strike price of EUR 0.929 (approximately NOK 11) per share. Upon full conversion, at maturity, of all amounts under the convertible loan (including accrued but unpaid interest and underwriting commission), up to a maximum of 61 million new shares shall be issued in the capital of the company.

The equity component of the convertible loan amounts to EUR 2.981.207 as of June 30, 2025 and December 31, 2024 based on the interest rate of comparable non-convertible loans with a mark-up of 2%. This equity portion relates to the loan agreement entered into with the group as stated above for the total amount of EUR 32.000k.

### Machias loan

Kingfish Maine Inc. has entered into a loan agreement with Machias Savings Bank for an amount of up to 2 million dollars (\$2.000.000) with a loan term of 24 months.

The purpose of the loan is for funds to be used as a bridge loan for working capital.

The loan has an interest rate which is linked to the Wall Street Journal prime rate or a rate equal to the floor rate (if applicable) whichever is greater. Interest is calculated on a 365/360-day basis. During the term of the loan, a Floor shall apply, and the interest rate shall not be lower than six and one quarter percent (6.25%).

| Figures in Euro thousand                                     | 6 months ended<br>30 June 2025 | 12 months ended<br>31 December 2024 |
|--------------------------------------------------------------|--------------------------------|-------------------------------------|
| 16.<br>Trade and other payables                              |                                |                                     |
| Financial instruments:                                       |                                |                                     |
| Trade payables                                               | 2.145                          | 2.130                               |
| Payables relating to taxes and social security contributions | 589                            | 535                                 |
| Accrued leave pay and holiday allowance                      | 336                            | 518                                 |
| Accrued bonus                                                | 111                            | 10                                  |
| Accrued expenses and fees to be paid                         | 125                            | 156                                 |
| Other accruals                                               | 1.316                          | 2.224                               |
|                                                              | 4.622                          | 5.573                               |

### 17. Deferred income

| Government grants have been received for the reimbursement of costs | 2025 | 2024 |
|---------------------------------------------------------------------|------|------|
| As at 1 January                                                     | 97   | 91   |
| Forex adjustment                                                    | (12) | 6    |
| As at 30 June/31 December                                           | 85   | 97   |
|                                                                     | 85   | 97   |

There are no unfulfilled conditions or contingencies attached to these grants and no significant decreases are expected in the level of government grants.

| Figures in Euro thousand | 6 months ended<br>30 June 2025 | 12 months ended<br>31 December 2024 |
|--------------------------|--------------------------------|-------------------------------------|
|                          |                                |                                     |

### 18. Provisions

| Reconciliation of provisions – 2025 | Opening balance | Utilized during the year | Total |
|-------------------------------------|-----------------|--------------------------|-------|
| Provision for closure costs         | 86              | (41)                     | 45    |
| Reconciliation of provisions – 2024 | Opening balance | Additions                | Total |
| Provision for closure costs         | –               | 86                       | 86    |

The group has recognized a provision for closure related costs due to the decision taken at year end 2024 to cease its hatchery operation in Maine, USA. The provision includes estimates for employee severance payments, legal and regulatory costs, professional services fees, communication and notification costs.

The provision is recognized in accordance with IAS 37 (provisions, contingent liabilities and asset). The estimated closure costs are 86k Euro, and these costs are expected to be incurred during the 2025 financial year.

#### Provision for closure costs

| Employee severance, legal, professional services, and | 86 |
|-------------------------------------------------------|----|
| communication costs                                   |    |

The provision has been recognized based on the best estimates of costs at 31 December 2024. The timing of these outflows of cash is uncertain but it is expected to occur within the next 12 months. Any revision to the estimated costs will be recognized as an adjustment to the provision in the future periods.

| Figures in Euro thousand                                     | 6 months ended<br>30 June 2025 | 6 months ended<br>30 June 2024 |
|--------------------------------------------------------------|--------------------------------|--------------------------------|
|                                                              |                                |                                |
| 19.<br>Revenue                                               |                                |                                |
| Revenue from contracts with customers                        |                                |                                |
| Sale of goods                                                | 17.046                         | 13.049                         |
| Disaggregation of revenue from contracts with customers      |                                |                                |
| The company disaggregates revenue from customers as follows: |                                |                                |
| Sale of goods                                                |                                |                                |
| Fish                                                         | 17.046                         | 13.049                         |
| Timing of revenue recognition                                |                                |                                |
| At a point in time                                           |                                |                                |
| Sale of goods                                                | 17.046                         | 13.049                         |
| Geographical markets                                         |                                |                                |
| Western Europe                                               | 4.780                          | 3.470                          |
| Southern Europe                                              | 8.781                          | 6.078                          |
| Rest of the World                                            | 3.485                          | 3.501                          |
|                                                              | 17.046                         | 13.049                         |

### 20. Other operating income

| Compensation received from claims | 44 | 84 |
|-----------------------------------|----|----|
|                                   |    |    |

### 21. Other operating gains (losses)

| Foreign exchange gains (losses)        |   |       |       |
|----------------------------------------|---|-------|-------|
| Net foreign exchange (losses) gains    |   | (166) | 3     |
| Fair value gains (losses)              |   |       |       |
| Biological assets                      | 5 | (77)  | 173   |
| Cash flow hedging ineffectiveness loss |   | (117) | (140) |
|                                        |   | (194) | 33    |
| Total other operating gains (losses)   |   | (360) | 36    |

| Figures in Euro thousand    | 6 months ended<br>30 June 2025 | 6 months ended<br>30 June 2024 |
|-----------------------------|--------------------------------|--------------------------------|
|                             |                                |                                |
| 22.<br>Cost of sales        |                                |                                |
| Transport and logistic cost | 1.283                          | 679                            |
| Stock movements             | 1.277                          | (2.415)                        |
| Live fish stock movements   | 1.463                          | (535)                          |
| Raw materials               | 8.467                          | 8.410                          |
|                             | 12.490                         | 6.139                          |

### 23. Operating profit (loss)

Operating loss for the 6 months is stated after charging (crediting) the following, amongst others:

| Auditor's remuneration – external                      |       |       |
|--------------------------------------------------------|-------|-------|
| Audit fees                                             | 145   | 93    |
| Tax and secretarial services                           | 7     | –     |
|                                                        | 152   | 93    |
| Employee costs                                         |       |       |
| Salaries, wages and other benefits                     | 5.262 | 4.878 |
| Share based compensation expense                       | 123   | 67    |
| Retirement benefit plans: defined contribution expense | 491   | 434   |
| Total employee costs                                   | 5.876 | 5.379 |
| Leases                                                 |       |       |
| Leases of short term and low value assets              | 142   | 233   |
| Depreciation and amortization                          |       |       |
| Depreciation of property, plant and equipment          | 6.815 | 6.631 |
| Depreciation of right-of-use assets                    | 315   | 508   |
| Amortization of intangible assets                      | 20    | 20    |
| Total depreciation and amortization                    | 7.150 | 7.159 |

### 24. Finance costs

| Net foreign exchange losses (gains) on foreign currency borrowings | 1.426 | (282) |
|--------------------------------------------------------------------|-------|-------|
| Lease liabilities                                                  | 27    | 31    |
| Borrowings – convertible loan                                      | 3.457 | 2.869 |
| Borrowings – other                                                 | 3.770 | 3.310 |
| Total finance costs                                                | 8.680 | 5.928 |

24 The Kingfish Company N.V. Group Interim Condensed Consolidated Financial Statements (Unaudited) for the 6 months ended 30 June 2025

| Figures in Euro thousand                                  | 6 months ended<br>30 June 2025 | 6 months ended<br>30 June 2024 |
|-----------------------------------------------------------|--------------------------------|--------------------------------|
|                                                           |                                |                                |
| 25.<br>Taxation                                           |                                |                                |
| Major components of the tax income                        |                                |                                |
| Deferred                                                  |                                |                                |
| Originating and reversing temporary differences           | (3.350)                        | (2.087)                        |
| Reconciliation of the tax expense                         |                                |                                |
| Reconciliation between accounting profit and tax expense. |                                |                                |
| Accounting loss                                           | (21.804)                       | (15.399)                       |
| Tax at the applicable tax rate of 25,8% (2024: 25,8%)     | (5.625)                        | (3.973)                        |
| Tax effect of adjustments on taxable income               |                                |                                |
| Non-deductible expenses                                   | 2.559                          | 1.872                          |
| Difference between tax and IFRS accounting policies       | 218                            | 84                             |
| US participants included                                  | (516)                          | (84)                           |
| Effect of lower tax bracket                               | 14                             | 14                             |
|                                                           | (3.350)                        | (2.087)                        |

### 26. Discontinued operations

On 31 December 2024, the group made a decision to cease operations and consolidate its hatchery (Yellowtail Hatchery Inc.) subsidiary located in Maine, United States of America, with its hatchery in the Netherlands. This strategic move enables the group to fully leverage advanced capabilities of the Dutch facility, ensuring high standards of quality, efficiency, and cost optimization across all operations. The group's commitment to U.S. expansion and the establishment of a farm in Jonesport remains unchanged. By centralizing hatchery operations, they can ensure that the future U.S. farm will receive the latest- generation fingerlings upon its launch. The consolidation was completed and finalized by early 2025. The hatchery business is classified as a discontinued operation under IFRS 5 (non-current assets held for sale and discontinued operations), as it represents a significant geographical area of operations and a separate major line of business.

The results of the discontinued operations, which have been included in the loss for the year, were as follows:

| Net loss attributable to discontinued operations | (406) | (204) |
|--------------------------------------------------|-------|-------|
| Attributable tax expense                         | –     | –     |
| Net loss after impairment                        | (406) | (204) |
| Impairment of assets                             | –     | –     |
| Expenses                                         | (406) | (204) |
| Revenue                                          | –     | –     |
| Profit and loss                                  |       |       |

| Figures in Euro thousand                       | 6 months ended<br>30 June 2025 | 6 months ended<br>30 June 2024 |
|------------------------------------------------|--------------------------------|--------------------------------|
| 27.<br>Cash flows from discontinued operations |                                |                                |
| Cash flows from operating activities           | (1)                            | (40)                           |
| Cash flows from investing activities           | –                              | (9)                            |
| Cash flows from financing activities           | –                              | –                              |
| Net cash flows from discontinued operations    | (1)                            | (49)                           |
|                                                |                                |                                |

### 28. Other comprehensive income

| Components of other comprehensive income – 2025                                  | Gross | Tax | Net  |
|----------------------------------------------------------------------------------|-------|-----|------|
| Items that may be reclassified to profit (loss)                                  |       |     |      |
| Exchange differences on translating foreign operations                           |       |     |      |
| Exchange differences arising during the year                                     | 762   | –   | 762  |
| Deferred cost of hedging on cash flow hedges not subject to<br>basis adjustments |       |     |      |
| Deferred cost of hedging                                                         | (56)  | –   | (56) |
| Total items that may be reclassified to profit (loss)                            | 706   | –   | 706  |
|                                                                                  |       |     |      |
| Components of other comprehensive income – 2024                                  | Gross | Tax | Net  |
| Items that may be reclassified to profit (loss)                                  |       |     |      |
| Exchange differences on translating foreign operations                           |       |     |      |
| Exchange differences arising during the year                                     | (63)  | –   | (63) |
| Deferred cost of hedging on cash flow hedges not subject to<br>basis adjustments |       |     |      |
| Deferred cost of hedging                                                         | (11)  | –   | (11) |

| Figures in Euro thousand                 | 6 months ended<br>30 June 2025 | 6 months ended<br>30 June 2024 |
|------------------------------------------|--------------------------------|--------------------------------|
|                                          |                                |                                |
| 29.<br>Cash utilized in operations       |                                |                                |
| Loss before taxation                     | (21.804)                       | (15.399)                       |
| Adjustments for:                         |                                |                                |
| Depreciation                             | 7.149                          | 7.246                          |
| Amortization on interest rate hedge      | 117                            | 140                            |
| Losses (gains) on foreign exchange       | 1.700                          | (499)                          |
| Finance costs                            | 7.570                          | 7.200                          |
| Fair value losses (gains)                | 1.612                          | (708)                          |
| Non-cash movement in right-of-use assets | 188                            | (67)                           |
| Employee share option expense            | 79                             | 58                             |
| Movement in provisions                   | 43                             | –                              |
| Changes in working capital:              |                                |                                |
| Inventories                              | 1.234                          | (2.135)                        |
| Trade and other receivables              | (619)                          | (193)                          |
| Trade and other payables                 | (878)                          | (1.168)                        |
| Deferred income                          | (12)                           | 2                              |
|                                          | (3.621)                        | (5.523)                        |

| Figures in Euro thousand                                                                                                                                                                                                                            | 6 months ended<br>30 June 2025 | 6 months ended<br>30 June 2024 |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------|--------------------------------|
|                                                                                                                                                                                                                                                     |                                |                                |
| 30.<br>Earnings per share                                                                                                                                                                                                                           |                                |                                |
| Basic earnings per share                                                                                                                                                                                                                            |                                |                                |
| Basic earnings per share is determined by dividing profit (loss) attributable<br>to the ordinary equity holders of the parent by the weighted average<br>number of ordinary shares outstanding during the 6 months.                                 |                                |                                |
| Where there is a discontinued operation, earnings per share is determined<br>for both continuing and discontinued operations.                                                                                                                       |                                |                                |
| Basic loss per share                                                                                                                                                                                                                                |                                |                                |
| From continuing operations (c per share)                                                                                                                                                                                                            | (0,12)                         | (0,11)                         |
| From discontinued operations (c per share)                                                                                                                                                                                                          | (0,01)                         | (0,01)                         |
|                                                                                                                                                                                                                                                     | (0,13)                         | (0,12)                         |
| Basic earnings per share was based on weighted average number of ordinary<br>shares of 138.471.539 (2024: 110.849.291).                                                                                                                             |                                |                                |
| Reconciliation of profit (loss) for the 6 months to basic earnings                                                                                                                                                                                  |                                |                                |
| Profit (loss) for the 6 months attributable to equity holders of the parent                                                                                                                                                                         | (18.454)                       | (13.312)                       |
| Diluted earnings per share                                                                                                                                                                                                                          |                                |                                |
| In the determination of diluted earnings per share, profit (loss) attributable to<br>the equity holders of the parent and the weighted average number of ordinary<br>shares are adjusted for the effects of all dilutive potential ordinary shares. |                                |                                |
| Where there is a discontinued operation, diluted earnings per share is<br>determined for both continuing and discontinued operations.                                                                                                               |                                |                                |
| Diluted loss per share                                                                                                                                                                                                                              |                                |                                |
| From continuing operations (c per share)                                                                                                                                                                                                            | (0,12)                         | (0,11)                         |
| From discontinued operations (c per share)                                                                                                                                                                                                          | (0,01)                         | (0,01)                         |
|                                                                                                                                                                                                                                                     | (0,13)                         | (0,12)                         |
| Diluted earnings per share was based on a weighted average number of<br>ordinary shares of 133.722.059 (2024: 107.760.555).                                                                                                                         |                                |                                |
| Reconciliation of basic earnings to earnings used to determine diluted<br>earnings per share                                                                                                                                                        |                                |                                |
| Basic loss                                                                                                                                                                                                                                          | (18.454)                       | (13.312)                       |
| Reconciliation of weighted average number of ordinary shares used for<br>earnings per share to weighted average number of ordinary shares used for<br>diluted earnings per share                                                                    |                                |                                |
| Weighted average number of ordinary shares used for basic earnings<br>per share                                                                                                                                                                     | 138.471                        | 110.849                        |
| Adjusted for:                                                                                                                                                                                                                                       |                                |                                |
| Options                                                                                                                                                                                                                                             | (4.749)                        | (3.089)                        |
|                                                                                                                                                                                                                                                     | 133.722                        | 107.760                        |

| Figures in Euro thousand | 6 months ended<br>30 June 2025 | 6 months ended<br>30 June 2024 |
|--------------------------|--------------------------------|--------------------------------|
|--------------------------|--------------------------------|--------------------------------|

### 31. Going concern

The interim condensed consolidated financial statements (unaudited) have been prepared on the basis of accounting policies applicable to a going concern. This basis presumes that funds will be available to finance future operations and that the realization of assets and settlement of liabilities, contingent obligations and commitments will occur in the ordinary course of business.

The directors have considered the Group's financial position, cash flow forecast, and operational outlook, and are of the view that the Group will have access to sufficient funding to meet its obligations as they fall due. While the Group continues to comply with its financial covenants as at the reporting date, there is a possibility that certain covenants could come under pressure or potentially be breached over the next 12 month in certain circumstances. In response, the Group is actively exploring a number of mitigation options. The mitigation options include, but not limited to, pricing optimization, growth acceleration in certain territories, operational efficiencies, cost-saving initiative, and potential adjustments to its financial structure.

We draw attention to the fact that at 30 June 2025, the Group had accumulated losses of EUR (83.422) and that the company's total assets exceed its liabilities by EUR 46.319. The financial results for the period reflect continued investment in scaling operations, and a notable increase in revenue compared to the prior year, signaling positive commercial momentum.

Management remains confident that the Group is well-positioned to continue as a going concern, based on the progress in revenue growth, stakeholder support, and its ability to adapt its financial strategy to support ongoing covenant compliance and liquidity needs.

### 32. Events after the reporting period

The Machias loan, originally maturing in July 2025, was extended with a new maturity date of 21 July 2040. Under the revised terms, the loan bears interest at 9.50% (fixed for the first 5 years) and there will be monthly principal and interest payments of approximately 17k EUR. This change alters the loan repayment structure and extends the duration of the liability. The revised terms are expected to reduce current liabilities and increase non-current liabilities.

### 33. Comparative figures

Certain comparative figures have been reclassified for presentation purposes.

### 34. Commitments

### Electricity hedge

The group has committed to purchase electricity at a fixed rate from ENGIE from 2024, for a period of 3 years, at a price of EUR 242k per annum, capped to 5 megawatt hours.

![](_page_31_Picture_0.jpeg)

**The Kingfish Company N.V.** Oost-Zeedijk 13, 4485 PM Kats The Netherlands

+31 (0) 113 74 54 61 www.thekingfishcompany.com

![](_page_31_Picture_3.jpeg)